체성분 분석기 시장 보고서 : 제품별, 최종사용자별, 지역별(2025-2033년)

The global body composition analyzers market size reached USD 830.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,547.7 Million by 2033, exhibiting a growth rate (CAGR) of 6.8% during 2025-2033. The escalating growth of the obese population, owing to passive lifestyles and unhealthy dietary habits, is stimulating the market.

Body Composition Analyzers Market Trends:

Integration of Artificial Intelligence and Machine Learning

The integration of artificial intelligence and machine learning in composition assessment devices enhances accuracy and user experience by detecting health dangers based on data trends and giving actionable improvement strategies, making them useful for both professional and personal use. In July 2024, Samsung Electronics announced the release of the Galaxy Ring, Galaxy Watch7, and Galaxy Watch Ultra, bringing the power of Galaxy AI to more people via wearables meant to enable end-to-end wellness experiences for everyone. This is increasing the body composition analyzers market price.

Rising Demand for Multifunctional Devices

Body composition analyzers, which can monitor heart rate, blood pressure, metabolic rate, and other indicators, are becoming increasingly popular. This is acting as a significant growth-inducing factor. Consumers want all-in-one health tracking systems that go beyond basic body composition assessments. In May 2024, Xiaomi launched its latest body composition scale, the Mijia Body Composition Scale S200, which features high-precision sensors, multi-purpose weighing capabilities, and comprehensive health metrics tracking.

Widespread Popularity of Wearable and Portable Devices

Wearable and portable health monitoring analyzers are becoming increasingly popular as individuals seek convenience and on-the-go health tracking. Smartwatches and handheld analyzers enable quick and easy monitoring of body fat, muscle mass, and other vital factors without large machinery. In March 2024, Amazfit introduced the body composition analyzer mat, which pairs with a smartwatch to improve health tracking. It uses bioelectrical impedance analysis (BIA) to obtain detailed body composition values.

Global Body Composition Analyzers Industry Segmentation:

Breakup by Product:

• Bioimpedance Analyzer
• Skinfold Calipers
• Hydrostatic Weighing Equipment
• Air Displacement Plethysmography
• Dual Energy X-Ray Absorptiometry
• Others

Bioimpedance analyzer, which accounts for a significant body composition analyzers market share, is widely used due to its non-invasive nature, utilizing electrical currents to assess body fat and muscle composition; InBody and Tanita are well-known brands that sell such devices. Skinfold calipers, a more manual and affordable method of measuring fat beneath the skin, are widely used in fitness tests. Hydrostatic weighing equipment, while exceedingly accurate, is less common due to the need for specialized water tanks. Air displacement plethysmography, as proven by the Bod Pod, uses air displacement to measure body volume and density, giving a non-invasive and accurate alternative. Dual energy X-ray absorptiometry (DEXA) is the gold standard for precise body composition analysis and is commonly used in medical contexts to assess bone.

Breakup by End User:

• Hospitals
• Fitness Clubs and Wellness Centers
• Academic and Research Centers
• Others

Hospitals utilize devices, such as DEXA scanners, to perform precise body composition measurements, particularly in the diagnosis of osteoporosis and the treatment of obesity-related illnesses. For example, GE Healthcare's DEXA machines are commonly used in medical facilities to assess bone density and fat distribution. Bioimpedance analyzers, such as those made by Tanita and InBody, are commonly used in fitness clubs and wellness centers to help clients track muscle mass, body fat, and overall fitness levels during routine check-ups or personal training sessions. Meanwhile, academic and research institutes use cutting-edge techniques such as hydrostatic weighing and air displacement plethysmography to undertake in-depth studies on health, fitness, and body composition.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

High obesity rates and strong demand from healthcare facilities and fitness centers are driving the market in North America. Besides this, increased health awareness and disposable income are augmenting the market in Asia Pacific. Europe's demand remains stable, owing to a focus on preventative healthcare and an aging population. Latin America is experiencing consistent growth as healthcare infrastructure improves and fitness trends gain popularity. Economic development and increased healthcare spending in the Middle East and Africa are fueling market advancement.

Competitive Landscape:

The research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• Bodystat Ltd.
• COSMED Srl
• GE Healthcare
• Hologic Inc.
• Inbody Co. Ltd.
• Omron Corporation
• RJL Systems Inc.
• Seca GmbH & Co. Kg.
• SELVAS Healthcare
• Tanita Corporation

Key Questions Answered in This Report:

• How has the global body composition analyzers market performed so far, and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global body composition analyzers market?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global body composition analyzers market, and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Body Composition Analyzers Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Bioimpedance Analyzer
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Skinfold Calipers
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Hydrostatic Weighing Equipment
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Air Displacement Plethysmography
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Dual Energy X-Ray Absorptiometry
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Fitness Clubs and Wellness Centers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Academic and Research Centers
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Bodystat Ltd.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 COSMED Srl
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 GE Healthcare
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 SWOT Analysis
  • 13.3.4 Hologic Inc.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Inbody Co. Ltd.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 Omron Corporation
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 RJL Systems Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Seca GmbH & Co. Kg.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 SELVAS Healthcare
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
  • 13.3.10 Tanita Corporation
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio